Lenacapavir
London activists push Gilead to lower price of new HIV drug
Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
- Israel suffers losses in ground battles in Lebanon and insists on escalating to regional war
- Claudia Sheinbaum sworn in as president of Mexico
- US threatens “severe consequences” for Iran
- Trade unions demand respect of rights as PM Barnier announces more austerity
- Hezbollah deputy leader delivers first speech since Nasrallah’s assassination
